Conversely a decreasing trend of resistance was observed for pyrazinamide, peaking in 2010 at 11.6% and is now reported to be 3.4% according to 2021 data.
← all excerpts
Epidemiology and antimicrobial resistance of <i>Mycobacterium</i> spp. in the United Arab Emirates: a retrospective analysis of 12 years of national antimicrobial resistance surveillance data.
2
—
—
The sentences
A slightly increasing trend of resistance among MTB-complex was observed for rifampicin from 2.5% (2010) to 2.8% (2021).